At Riverside Urology we recognize that disease of any kind can put a patient's life in turmoil. Our focus upon patient quality of life leads us to seek least-invasive solutions leading to best outcomes with minimal life disruption. Our patients benefit from access to the best care, the deepest knowledge and the use of our Ambulatory Surgery Center as an alternative to hospital stays. We help you get your life back to normal as quickly as possible.

Tuesday, April 1, 2014

PSA and PCA3



Prostate cancer is second, only to lung cancer, as the cause of cancer-related deaths in men. Roughly 250,000 new cases were diagnosed in 2013. Approximately 34,000 men will die annually from this disease.
PSA blood testing has raised the awareness of prostate cancer. It is a very sensitive test that determines activity with the prostate; however a high PSA may be indication of an enlarged, benign prostate. Therefore PSA results do require further testing to in order to diagnose prostate cancer.
New technology is changing the way we think about the treatment of prostate cancer. PCA3 is a urine test that is very specific in its ability to identify prostate cancer. PCA3 is a protein produced in normal prostate cells, however when malignancy is present, the amount of PCA3 in the urine is much higher. This is a FDA approved test and is a welcome noninvasive test.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)